Manpreet Mundi

@mmundi.bsky.social

Professor of Medicine with clinical and research focus in obesity as well as inpatient and outpatient nutrition support.

Our toolbox for management of #obesity continues to grow with phase 3 data being released today for the combination of cagrilinitide and semaglutide. Average weight loss for the combined drugs was over 20% and side-effect profile was similar to semaglutide. #Medsky 🧪🍎 www.nejm.org/doi/full/10....

Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity | NEJM

Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg has shown promising results in early-phase trials; the efficacy of the ...

nejm.org

This is such an amazing study. Researchers tracked people over 300,000 births looking at how biomarkers change & recover postpartum. ~60% stabilise close to pre-conception levels after 3 months, but some (eg for bone & liver health) take a year. Others never recover! 🧪 www.nature.com/articles/d41...

Gigantic birth study paints most detailed picture of pregnancy’s toll on body

Data from 300,000 births reveal how essential biological measurements are altered by carrying and delivering a baby.

nature.com

Are tirzepatide and semaglutide cost effective? Although they would reduce 20,854 & 19,211 cases of DM2 and 10,655 and 8263 cases of CVD per 100K respectively, their prices would require a 30.5% and 81.9% reduction from current price to be “cost-effective" #Medsky 🧪 jamanetwork.com/journals/jam...

Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults

This study compares the cost-effectiveness of 4 antiobesity medications (naltrexone-bupropion, phentermine-topiramate, semaglutide, or tirzepatide) with lifestyle modification vs lifestyle modificatio...

jamanetwork.com

We do see similar rapid weight loss with bariatric surgery. So medication selection, ie the correct medication based on BMI and medical co-morbidities will be key. 🧪 #obesity #Medsky

Daniel Drucker@danieljdrucker.bsky.social · 2y ago

Next generation GLP-1 medicines for #weightloss Too much weight loss, too fast? @elaineywchen.bsky.social foreshadows experiences in the ongoing Retatrutide trials, and discusses broader implications for the field @statnews.com #obesity @matthewherper.bsky.social www.statnews.com/2025/02/20/t...

Are GLP-1 receptor agonists associated with higher risk of thyroid cancer. It looks like there is only an increase in the first year most likely due to increased vigilance. Overall no increase compared to other diabetes medications. #Medsky #Obesity 🧪 jamanetwork.com/journals/jam...

GLP-1RA Use and Thyroid Cancer Risk

This secondary analysis of a target trial emulation of a comparative effectiveness study uses claims data to estimate the risk of incident thyroid cancer in adults with type 2 diabetes starting treatm...

jamanetwork.com

More real world data regarding benefits and side effects of GLP-1 agonists. Used VA database to compare patients w/ DM who used GLP-1 versus other meds. In addition to cardiometabolic benefits, also reduced substance abuse, psychotic disorders. #obesity #Medsky 🧪 www.nature.com/articles/s41...

Mapping the effectiveness and risks of GLP-1 receptor agonists - Nature Medicine

An atlas of the associations between the use of GLP-1 receptor agonists (GLP-1RAs) and 175 health outcomes reports the effectiveness and risks of GLP-1RAs compared with other antihyperglycemic medicat...

nature.com